Cyclobenzaprine HCl Tablets / 7.5 mg / 100 Count

Cyclobenzaprine HCl Tablets

7.5 mg / 100 Count
Back to Products

Brand name: Fexmid®

Cyclobenzaprine HCl is indicated as an adjunct to rest and physical therapy for relief of muscle spasm associated with acute, painful musculoskeletal conditions.

Improvement is manifested by relief of muscle spasm and its associated signs and symptoms, namely, pain, tenderness, limitation of motion, and restriction in activities of daily living.

Cyclobenzaprine HCl should be used only for short periods (up to two or three weeks) because adequate evidence of effectiveness for more prolonged use is not available and because muscle spasm associated with acute, painful musculoskeletal conditions is generally of short duration and specific therapy for longer periods is seldom warranted.

Cyclobenzaprine HCl has not been found effective in the treatment of spasticity associated with cerebral or spinal cord disease, or in children with cerebral palsy.

For more information please see the prescribing information on DailyMed.

Product Information
Product Name Cyclobenzaprine HCl Tablets
Strength 7.5 mg
Strength 7.5 mg
Dosage Form Tablets
Pack Size 100 Count
NDC 57237-266-01
OTC/Rx Rx
TE Code AB
Product Characteristics
Color White
Shape Round
Gluten Free from Gluten
Lactose Free from Lactose
Sweeteners Free from Sweeteners
Soy Free from Soy
Gelatin Free from Gelatin
Allergen Info Free from Diary, Corn, Starch, Sorbitol, Glycerin
Other Product Info Not Applicable
Other Information
Inactive Ingredients

Colloidal silicon dioxide, croscarmellose sodium, dibasic calcium phosphate, hydroxypropyl cellulose, hypromellose, polyethylene glycol, magnesium stearate, microcrystalline cellulose, and titanium dioxide.

Imprint/Markings WATSON;3330
Special Instructions

Store at 20° to 25°C (68° to 77°F) [See USP Controlled Room Temperature].

Product Shelf Life 24 months

*The brand names listed are not owned by Rising Pharma. Rising Pharma products are generic equivalents to the respective brand names listed on this website.